✦ LIBER ✦

PCN100 COST-EFFECTIVENESS OF GEFITINIB VERSUS DOUBLET CHEMOTHERAPY IN FIRST-LINE TREATMENT OF NON-SMALL CELL LUNG CANCER (NSCLC) IN SWEDEN

✍ Scribed by J Jacob; M Henriksson; D Brattström

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCN11 GEFITINIB COMPARED WITH DOUBLET CH

✍ SJ Edwards; N Welton; J Borrill 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB

PCN6: MODELLING THE COST-EFFECTIVENESS O

✍ P Sharplin; UK Bose; J Holmes 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

PCN34 COST-EFFECTIVENESS OF GEFITINIB FO

✍ PH Liu; FC Hu; JD Wang 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

PCN7 COMPARATIVE EFFECTIVENESS ASSESSMEN

✍ B. Schwander; J. de Castro Carpeño; D.F. Heigener; E. Wright; H.G. Bischoff; S. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

PCN82 Cost-Effectiveness Analysis of Erl

✍ P. Garrido; G. López-Vivanco; R. Rosell; B. Espinós; A. Castro-Gomez 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

PCN107 FIRST-LINE TREATMENT OF METASTATI

✍ S Stanisic; Carpeño JD Castro; S Walzer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB